Advertisement
Survey Series
For Advertisers
|
|
||||
|
Biotechs Put Initial Public Offerings on Hold
Weak market makes tried-and-true method of fundraising a disappointment in 2004
The Scientist 2004, 18(19):40
|
||||
|
|
||||
|
Companies typically use their first-time listing on a stock exchange, known as the initial public offering (IPO), as a crucial one-time opportunity to generate cash. However, a run of disappointing biotech market debuts over the summer has caused many biotechnology companies to put their IPOs on hold or cancel them altogether.
|
|
|||||||||
|
|||||||||
|
